Carlota Aguilera Ordoñez My name is Carla Aguilera, I have been the Project Manager of SIOPEN (European Society for Pediatric Oncology - Neuroblastoma Research Network) since 2024. Instituciones de las que forman parte Técnico de investigación Cáncer y Enfermedades Hematológicas Infantiles Vall Hebron Institut de Recerca Project Manager Oncología y Hematología Pediátrica Hospital Infantil i Hospital de la Mujer LinkedIn Twitter Orcid Carlota Aguilera Ordoñez LinkedIn Twitter Orcid Instituciones de las que forman parte Técnico de investigación Cáncer y Enfermedades Hematológicas Infantiles Vall Hebron Institut de Recerca Project Manager Oncología y Hematología Pediátrica Hospital Infantil i Hospital de la Mujer My name is Carla Aguilera, I have been the Project Manager of SIOPEN (European Society for Pediatric Oncology - Neuroblastoma Research Network) since 2024.
Graduated in Biology at the UdG and a master's degree in clinical trial monitoring at the UdL. I have completed continuing education in different courses related to the world of trials, from start-up to patient engagement, to managing requests to the ethics committee for new studies. I also have training in good clinical practices and sample management protocols. In the Department of Pediatric Onco-Hematology at Vall d'Hebron Hospital, I was Senior Clinical Trials Coordinator from 2018 to 2024 and Trial Site Manager from 2020 to 2024. I worked with the team to improve the care of patients participating in clinical trials and promote and manage research projects with the Childhood Cancer and Hematological Diseases group at the VHIR. Currently, and since May 2024, I am the Manager of SIOPEN (European Society for Paediatric Oncology -Neuroblastoma Research Network). The association brings together healthcare professionals from across Europe to improve outcomes for patients with neuroblastoma.
Proyectos Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders IP: Lucas Moreno Martín-Retortillo Colaboradores: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia, Victoria Gutierrez Valle, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Amira Idrizovic Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: 60000 Referencia: 2021 SGR 00638 Duración: 01/01/2022 - 30/06/2025 A phase I trial of ABTL0812 in paediatric patients with advanced cancer including neuroblastoma IP: Lucas Moreno Martín-Retortillo Colaboradores: Cristina Gamez Cenzano, Aroa Soriano Fernández, Luis Riera Soler, Miguel Segura Ginard, Carlota Aguilera Ordoñez Entidad financiadora: Instituto de Salud Carlos III Financiación: 826760.77 Referencia: ICI21/00076 Duración: 01/01/2022 - 31/12/2025
